Chondroitinase ABC isolated from proteus vulgaris ATCC 6896
AssigneeSeikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation)
InventorsNobukazu Hashimoto, Hideo Mochizuki, Akio Hamai
Life of this patent
Estimating the term…
Loading patent…
AssigneeSeikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation)
InventorsNobukazu Hashimoto, Hideo Mochizuki, Akio Hamai
Estimating the term…
A crystallizable, purified chondroitinase ABC having a molecular weight of about 100,000 dalton by the measurement of the SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and the measurement by the gel permeation chromatography method, having alanine as the N-terminal amino acid and proline as the C-terminal amino acid. A process for the purification of the crystallizable purified chondroitinase ABC comprising removing nucleic acid from an surfactant solution extract obtained from cells of chondroitinase ABC-producing microorganisms and chromatographically treating by concentration gradient elution using a weak cation exchange resin or a strong cation exchange resin. A composition comprising a chondroitinase and serum albumin, gelatin, or a nonionic surfactant. The chondroitinase ABC is isolated from Proteus vulgaris ATCC 6896.
A purified chondroitinase ABC from Proteus vulgaris ATCC 6896 having the following characteristics:
Dependencies are inferred from the claim text.